GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing. - Wikidata - awgldk - TriplyDB

GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing.

GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing.

http://www.wikidata.org/entity/Q37672327

about

A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells Control of gene editing by manipulation of DNA repair mechanisms.High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells

P2860

Q37273975-D5B35A82-8903-4647-B581-8544412C7FC2 Q48325841-12CBDDAD-7FDC-492C-97EE-428F7A7A7763 Q57477219-125C8DA7-CAF5-49A6-BA75-213F21FEC6E3

P2860

GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing.

http://www.wikidata.org/entity/Q37672327

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

GFP to BFP Conversion: A Versa ...... /Cas9-mediated Genome Editing.

@en

GFP to BFP Conversion: A Versa ...... /Cas9-mediated Genome Editing.

@nl

type

label

GFP to BFP Conversion: A Versa ...... /Cas9-mediated Genome Editing.

@en

GFP to BFP Conversion: A Versa ...... /Cas9-mediated Genome Editing.

@nl

prefLabel

GFP to BFP Conversion: A Versa ...... /Cas9-mediated Genome Editing.

@en

GFP to BFP Conversion: A Versa ...... /Cas9-mediated Genome Editing.

@nl

P1433

Q37672327-1BB16347-B32C-47D2-8A35-2C9B2C7D549E

P1476

Q37672327-EF09D08A-0342-4FAF-B2AB-71B7305323E6

P2093

Q37672327-9D47D940-5013-4C34-AD1D-BFFABA4A1278

Q37672327-C77A5CEA-7E9C-4E94-A819-677AB850C0F9

P2860

Q37672327-04BEC09D-0C13-4D6A-B50C-9C05761C9002

Q37672327-06B57BC0-F88B-4929-AF5F-B9EB538AC3BE

Q37672327-0BA2D411-A1B5-41CD-AFAE-349FD3E9EB9E

Q37672327-266CD79A-D5F6-4631-8EB2-0E99A7D79C2D

Q37672327-42AB8765-40DD-4857-ABE6-556A7360DE0D

Q37672327-42C96550-5B8A-4331-A83C-32B677797DAE

Q37672327-67776F0C-C30D-47E2-B162-9A775F99CF94

Q37672327-741935B1-32E9-460B-A9E3-92B3E007133A

Q37672327-84F5219C-6B91-4F2C-A203-F822A1528C7A

Q37672327-944ADBA1-755C-4F18-A513-926E119E2167

P304

Q37672327-C7B0A292-BDB9-483E-9F7C-C4807B723046

P31

Q37672327-38F75BE3-6B5C-4C4B-BE92-61E657766C71

P356

Q37672327-D1B40829-C299-4106-9CF4-B9266C7BD1C5

P433

Q37672327-5BAF69A4-90BE-446C-A0B7-E1E1508107C9

P478

Q37672327-12591903-F0D1-444B-9E32-497FE095A163

P50

Q37672327-0188AF61-AB58-472D-828E-C4FC41005F4E

P577

Q37672327-9DA7603A-1A5E-4477-9125-DAA80FAE6913

P698

Q37672327-27EFAA65-CE2E-416D-A71B-BE3A50F0A6A2

P921

Q37672327-AE85DA21-73D3-4610-9BD2-86EC76940F1F

P932

Q37672327-56CF58D3-A50C-42DC-A62F-C12C4825AF29

P356

P1433

Molecular therapy. Nucleic acids

P1476

GFP to BFP Conversion: A Versa ...... R/Cas9-mediated Genome Editing

@en

P2093

Bradley McColl

http://www.w3.org/2001/XMLSchema#string

Jim Vadolas

http://www.w3.org/2001/XMLSchema#string

P2860

Genome engineering using the CRISPR-Cas9 system

Random Single Amino Acid Deletion Sampling Unveils Structural Tolerance and the Benefits of Helical Registry Shift on GFP Folding and Structure

Genome editing. The new frontier of genome engineering with CRISPR-Cas9

Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing.

Isolation of single-base genome-edited human iPS cells without antibiotic selection.

Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.

Wavelength mutations and posttranslational autoxidation of green fluorescent protein.

Tracking genome engineering outcome at individual DNA breakpoints

Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease

P304

e334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTNA.2016.48

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27404719

http://www.w3.org/2001/XMLSchema#string

P921

P932

5330940

http://www.w3.org/2001/XMLSchema#string